Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Terminated2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

Research Network

Collaboration Network

35 collaborators·76 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Maryland

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

lei zhang, MD

Chinese Academy of Medical Science and Blood Disease Hospital

Moderately Similar
19 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia
Similarity Score30%

Joseph Kiss, MD

University of Pittsburgh

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

David Kuter, MD

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Ellis Neufeld, MD

Boston Children's Hospital

Related
6 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Judith Lin, MD

Brigham and Women's Hospital

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Cindy Leissinger, MD

Tulane University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Terry Gernsheimer, MD

University of Washington

Related
4 trials

Shared therapeutic areas:

ThrombocytopeniaPurpura, Thrombocytopenic, Idiopathic

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Neal S Young, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
15 trials

Shared therapeutic areas:

Thrombocytopenia

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score15%

Zhen Zhang, MD

Fudan University

Related
9 trials

Shared therapeutic areas:

Thrombocytopenia
Similarity Score15%

heng Mei

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00594685PrincipalInvestigator

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

Thrombocytopenia
Terminated
NCT00991939Phase 3PrincipalInvestigator

Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Immune Thrombocytopenic Purpura
Terminated

All 2 trials loaded